Live Webinar | Operations and Other Technology
Save
Live Webinar | Operations and Other Technology
Save
Live Webinar | Patient Financial Communications
Save
Blog | Care Management

HHS to provide funding for administration of COVID-19 advanced therapies in vulnerable communities

Blog | Care Management

HHS to provide funding for administration of COVID-19 advanced therapies in vulnerable communities

The U.S. Department of Health and Human Services announced a $150 million investment to make monoclonal antibody therapeutic treatments available for patients in vulnerable communities nationwide.

The initiative is part of an effort to promote health equity in response to the COVID-19 pandemic, HHS announced March 17.

The funding is designed to increase administration of monoclonal antibody treatments in “hard-hit communities,” according to a news release. The therapy was made available on an emergency basis by the Food and Drug Administration and has been shown to be safe and effective at preventing hospitalization and death in patients with early-stage COVID-19. The National Institutes of Health recommends the treatments for non-hospitalized COVID-19 patients who are deemed to be at high risk of developing severe disease.

“Assistance may include additional staffing, infusion center capacity in traditional and non-traditional health care settings, and equipment to administer the intravenous infusion treatments,” HHS stated. “The effort will also increase awareness among health care providers and patients about the treatment options available, including where and how to access them.”

The announcement did not include information on the process by which funding will be allocated. Distributions will be made to communities that have a high prevalence of COVID-19 and are determined to be particularly at risk based on the CDC’s social vulnerability index, which uses 15 U.S. census variables to indicate vulnerable communities.

About the Author

Nick Hut

is a senior editor with HFMA, Westchester, Ill. (nhut@hfma.org).

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Care Management

Blog | Cost of Care

Healthcare News of Note: Cancer is now the top driver of large employers’ healthcare costs

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: The No. 1 driver of healthcare costs for large employers is cancer, the gender pay gap for physicians has gotten larger, and NRC Health names the top facilities for consumer loyalty and patient experience.

Blog | Patient Experience

Healthcare News of Note: Americans have less confidence in the nation’s healthcare system

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: Confidence in the U.S. healthcare system dips again, the median proposed health insurance premium increase for 2023 is about 10%, and improved oral care in hospitals can prevent pneumonia.

Blog | Cost Effectiveness of Health

Healthcare News of Note: U.S. hospitals performed 106,474 unnecessary procedures on older adults during the ‘dangerous’ first year of COVID-19

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: 106,474 unnecessary procedures were performed on older adults in hospitals early in the pandemic, 55% of patients in rural areas relied on telehealth to receive outpatient mental health and substance use services in March-August 2021, and women and people of color with chest pain wait longer to be seen by a physician.

News | Cost Effectiveness of Health

Healthcare News of Note: Medicare would save $8 billion a year if all hospitals achieved the outcomes of the most cost-efficient performers, says Lown Institute

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: America’s most cost-effective hospitals are identified, employers have boosted telemedicine and mental health benefits during the pandemic, and risk-based Medicare Advantage models gain popularity with health systems.